ArticleArthritis care & research2026

​Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

HaoHung Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.